Search results for "kidney"

showing 10 items of 1514 documents

KIAA0556 is a novel ciliary basal body component mutated in Joubert syndrome

2015

Background Joubert syndrome (JBTS) and related disorders are defined by cerebellar malformation (molar tooth sign), together with neurological symptoms of variable expressivity. The ciliary basis of Joubert syndrome related disorders frequently extends the phenotype to tissues such as the eye, kidney, skeleton and craniofacial structures. Results Using autozygome and exome analyses, we identified a null mutation in KIAA0556 in a multiplex consanguineous family with hallmark features of mild Joubert syndrome. Patient-derived fibroblasts displayed reduced ciliogenesis potential and abnormally elongated cilia. Investigation of disease pathophysiology revealed that Kiaa0556-/- null mice possess…

AdultMaleK04F10.2KIAA0556MicrotubuleMicrotubulesRetinaMiceJoubert syndromeCerebellumAnimalsHumansAbnormalities MultipleExomeCiliaEye AbnormalitiesSensory disorders Radboud Institute for Molecular Life Sciences [Radboudumc 12]Caenorhabditis elegansChildCells CulturedAdenosine TriphosphatasesADP-Ribosylation FactorsResearchBrainMetabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6]Kidney Diseases CysticBasal BodiesPedigreeMice Inbred C57BLRenal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11]Basal bodyChild PreschoolMutationFemaleKataninMicrotubule-Associated ProteinsProtein BindingGenome Biology
researchProduct

Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery

2002

Background Ketorolac is approved for the relief of postoperative pain but concerns have been raised over a possible risk of serious adverse effects and death. Two regulatory reviews in Europe on the safety of ketorolac found the data were inconclusive and lacked comparison with other non-steroidal anti-inflammatory drugs. The aim of this study was to compare the risk of serious adverse effects with ketorolac vs diclofenac or ketoprofen in adult patients after elective major surgery. Methods This prospective, randomized multicentre trial evaluated the risks of death, increased surgical site bleeding, gastrointestinal bleeding, acute renal failure, and allergic reactions, with ketorolac vs di…

AdultMaleKetoprofenGastrointestinal bleedingmedicine.medical_specialtyDiclofenacAnalgesicBlood Loss Surgicallaw.inventionDrug HypersensitivityDiclofenacRandomized controlled trialRisk FactorslawmedicineHumansCyclooxygenase InhibitorsProspective StudiesAdverse effectAgedAged 80 and overPain Postoperativebusiness.industryAnti-Inflammatory Agents Non-SteroidalAnticoagulantsAcute Kidney InjuryMiddle Agedmedicine.diseaseSurgerybody regionsKetorolacClinical trialstomatognathic diseasesAnesthesiology and Pain MedicineKetoprofenAnesthesiaFemalebusinessKetorolacmedicine.drug
researchProduct

Human chromophobe cell renal carcinoma

1985

Twelve renal cell carcinomas composed of "chromophobe" cells are described. This is the first report of renal chromophobe cell tumors in humans neoplasms of this cell type having been described previously only in experimentally induced adenomas in animals. By light microscopy chromophobe cells have slightly opaque or finely reticular cytoplasm when stained with haematoxylin and eosin. They may be distinguished from the clear cells of hypernephroid renal cell carcinomas by the strongly positive reaction of their cytoplasm with Hale's (1946) colloidal iron method and the weaker positive reaction with alcian blue. Vesicular structures, often containing internal vesicles, and possibly derived f…

AdultMaleKidneyPathologymedicine.medical_specialtyCell typeChromophobe Renal Cell CarcinomaCellChromophobe cellMiddle AgedBiologyurologic and male genital diseasesmedicine.diseaseKidney NeoplasmsMicroscopy Electronstomatognathic diseasesmedicine.anatomical_structureRenal cell carcinomamedicineHumansChromophobe cell renal carcinomaFemaleCarcinoma Renal CellAgedVirchows Archiv B Cell Pathology Including Molecular Pathology
researchProduct

Quality of Life and Stressors in Patients with Chronic Kidney Disease Depending on Treatment

2015

AbstractThis study evaluated health-related quality of life (HRQOL) in a Spanish sample of chronic kidney disease patients (n= 90) undergoing different renal replacement therapies, considering the influence of treatment stressors, mood, anxiety and quality of sleep. While all patients had worse physical functioning than controls (p< .01), only those undergoing haemodialysis (HD) showed worse physical well-being, occupational functioning, spiritual fulfillment and more health interference with work (p< .05). They also obtained higher depression scores than renal transplant patients (TX) (p= .005). Those TX receiving the immunosuppressor sirolimus exhibited more cardiac/renal, cognitive…

AdultMaleLinguistics and Languagemedicine.medical_specialtymedicine.medical_treatmentLanguage and LinguisticsPeritoneal dialysisYoung AdultQuality of lifeInternal medicinemedicineHumansRenal Insufficiency ChronicGeneral PsychologyDialysisDepression (differential diagnoses)AgedStressorMiddle Agedmedicine.diseaseRenal Replacement TherapyMoodQuality of LifeAnxietyFemalemedicine.symptomPsychologyStress PsychologicalClinical psychologyKidney diseaseThe Spanish Journal of Psychology
researchProduct

Postmortem distribution of dihydrocodeine and metabolites in a fatal case of dihydrocodeine intoxication.

1998

A report of a fatal dihydrocodeine ingestion under substitution therapy is given. Quantitation of dihydrocodeine, dihydromorphine, N-nordihydrocodeine, dihydrocodeine-6-, dihydromorphine-6- and dihydromorphine-3-glucuronide was performed simultaneously after solid-phase extraction prior to HPLC analysis, and the analytes were detected using their native fluorescence. Postmortem concentrations of blood samples from different sampling sites as well as from liver, kidney and cerebrum are reported. A hair sample was investigated to prove long-term use of the substitute drug. Site-to-site differences of the analytes from blood samples were very small. The partition behavior of the opioid glucuro…

AdultMaleMetaboliteDihydromorphineHematocritKidneyGas Chromatography-Mass SpectrometryPathology and Forensic Medicinechemistry.chemical_compoundFatal OutcomePharmacokineticsMedicineHumansActive metaboliteChromatography High Pressure LiquidBrain ChemistryMorphine DerivativesChromatographymedicine.diagnostic_testbusiness.industryCodeineCodeineDihydrocodeineAnalgesics OpioidchemistryLiverAnesthesiaDihydromorphinePostmortem ChangesToxicitybusinessLawBlood Chemical Analysismedicine.drugHairForensic science international
researchProduct

Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries

2005

Background. Amphotericin B is a widely used broad-spectrum antifungal agent, despite being associated with significant adverse events, including nephrotoxicity. Methods. The present prospective study collected data on outcomes for 418 adult patients treated consecutively with polyenes in hematology and oncology wards in 20 hospitals in Europe. Results. Patients initially received amphotericin B deoxycholate (62% of patients), liposomal amphotericin B (27%), or other lipid formulations of amphotericin B (11%). Of the patients initially treated with amphotericin B deoxycholate, 36% had therapy switched to lipid formulations of amphotericin B, primarily because of increased serum creatinine le…

AdultMaleMicrobiology (medical)medicine.medical_specialtyAntifungal AgentsRenal functionPolyenesGastroenterologyNephrotoxicityImmunocompromised HostAmphotericin BAmphotericin B deoxycholateInternal medicineAmphotericin BmedicineHumansProspective StudiesAdverse effectProspective cohort studyAgedHematologybusiness.industryMortality rateLength of StayMiddle AgedSurgeryEuropeInfectious DiseasesMycosesFemaleKidney Diseasesbusinessmedicine.drug
researchProduct

Comparing extracorporeal shock wave lithotripsy and ureteroscopy laser lithotripsy for treatment of urinary stones smaller than 2 cm: a cost-utility …

2021

[EN] Purpose To analyze the efficiency and cost-utility profile of ureteroscopy versus shock wave lithotripsy for treatment of reno-ureteral stones smaller than 2 cm. Methods Patients treated for urinary stones smaller than 2 cm were included in this study (n = 750) and divided into two groups based on technique of treatment. To assess the cost-utility profile a sample of 48 patients (50% of each group) was evaluated. Quality of life survey (Euroqol 5QD-3L) before-after treatment was applied, Markov model was designed to calculate quality of life in each status of the patients (stone or stone-free with and without double-J stent) and to estimate the incremental cost-utility. Monte carlo sim…

AdultMaleNephrologyQuality of lifemedicine.medical_specialtyUreteral CalculiCost-Benefit AnalysisUrologymedicine.medical_treatment030232 urology & nephrologyUrologySubgroup analysisLithotripsyUrinary calculiKidney Calculi03 medical and health sciences0302 clinical medicineInternal medicineLithotripsymedicineUreteroscopyHumansUrologiaQuality-adjusted life yearsUreteroscopyAgedmedicine.diagnostic_testbusiness.industryStentMiddle AgedLithotripsy LaserLaser lithotripsyExtracorporeal shock wave lithotripsyQuality-adjusted life yearTreatment OutcomeSpain030220 oncology & carcinogenesisFemalebusiness
researchProduct

Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis

2011

We tested for the presence of coronary calcifications in patients with chronic renal disease not on dialysis and studied its progression in 181 consecutive non-dialyzed patients who were followed for a median of 745 days. Coronary calcifications (calcium score) were tallied in Agatston units by computed tomography, and the patients were stratified into two groups by their baseline calcium score (100 U or less and over 100 U). Survival was measured by baseline calcium score and its progression. Cardiac death and myocardial infarction occurred in 29 patients and were significantly more frequent in those patients with calcium scores over 100 U (hazard ratio of 4.11). With a calcium score of 10…

AdultMaleNephrologymedicine.medical_specialtySettore MED/09 - Medicina Internamedicine.medical_treatmentMyocardial Infarctioncardiovascular events chronic kidney disease coronary calcificationCoronary Artery DiseaseKaplan-Meier EstimateCohort StudiesCoronary artery diseasecardiovascular eventsRisk FactorsCalcinosisInternal medicinemedicineHumansMyocardial infarctionRenal Insufficiency ChronicDialysisAgedSettore MED/14 - Nefrologiabusiness.industryHazard ratiocoronary calcificationCalcinosisMiddle AgedPrognosismedicine.diseasecardiovascular eventSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSettore MED/11 - Malattie Dell'Apparato CardiovascolareSurgeryNephrologyDisease ProgressionCardiologyFemaleOriginal Articlebusinesschronic kidney diseaseKidney diseaseCalcification
researchProduct

Oxidative stress and inflammation in long-term renal transplanted hypertensives.

2006

INTRODUCTION Several studies have shown that chronic renal failure (CRF) is characterized by "accelerated atherosclerosis". More recent studies emphasize that inflammation and oxidative stress play a central role in atherosclerosis, and it is well-established that C-reactive protein (CRP) is a cardiovascular risk marker in the general population, in end-stage renal disease (ESRD) patients and in allograft recipients. METHODS We measured the serum concentration of high sensitivity CRP, TNFalpha, 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha, an in vivo oxidative stress marker) in 15 CRF patients and in 15 transplant recipients. Exclusion criteria were age 65 years, smoking, diabetes mellitus …

AdultMaleNephrologymedicine.medical_specialtyTime FactorsPopulationRenal functionDinoprostchemistry.chemical_compoundInternal medicineDiabetes mellitusmedicineHumanseducationeducation.field_of_studyCreatinineTumor Necrosis Factor-alphabusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseKidney Transplantationoxidative stress inflammation hypertension renal transplantationTransplantationOxidative StressC-Reactive ProteinEndocrinologyBlood pressurechemistryNephrologyCase-Control StudiesHypertensionKidney Failure ChronicInflammation MediatorsbusinessKidney disease
researchProduct

Short-Term Functional and Oncologic Outcomes of Nephron-Sparing Surgery for Renal Tumours ≥7cm

2011

Abstract Background Nephron-sparing surgery (NSS) for renal tumours preserves renal function and has become the standard approach for small renal tumours. Little is known about perioperative and oncologic outcomes of patients following NSS in renal tumours ≥7cm in the presence of a healthy contralateral kidney. Objective To analyse oncologic outcomes and perioperative morbidity in patients treated by NSS for renal tumours ≥7cm. Design, setting, and participants In total, 5767 patients were treated for renal tumours at two institutions from 1984 to 2009. In 91 patients, elective NSS was performed for renal tumours ≥7cm. Measurements Complication rates were assessed in detail and stratified u…

AdultMaleNephrologymedicine.medical_specialtyTime FactorsUrologymedicine.medical_treatmentKaplan-Meier EstimateNephrectomyRisk AssessmentDisease-Free SurvivalRisk FactorsRenal cell carcinomaGermanyInternal medicinemedicineHumansMinimally Invasive Surgical ProceduresSurvival rateAgedNeoplasm StagingRetrospective StudiesAged 80 and overUnivariate analysisbusiness.industryPatient SelectionPerioperativeMiddle Agedmedicine.diseaseKidney NeoplasmsNephrectomyTumor BurdenSurgerySurvival RateLogistic ModelsTreatment OutcomeFemalebusinessKidney cancerKidney diseaseEuropean Urology
researchProduct